How Has the Artificial Kidney Market Evolved Historically and What is its Current Size?
The artificial kidney market has seen considerable growth due to a variety of factors.
•The growth of the artificial kidney market has been swift in recent times, expanding from a size of $10.22 billion in 2024 to an estimated $11.51 billion in 2025. This translates to a compound annual growth rate (CAGR) of 12.6%.
Numerous factors can be cited as being responsible for this growth during the historic period, such as a rise in chronic kidney disease (CKD) cases, a shortage of donor organs, advancements in renal replacement therapies, improvements in the quality of life for patients with end-stage renal disease (ESRD), and a growing aged population.
What is the Forecasted Market Size and CAGR for the Artificial Kidney Market?
The artificial kidney market is expected to maintain its strong growth trajectory in upcoming years.
• The sector of artificial kidneys is predicted to experience a swift expansion in the forthcoming years. It is estimated to escalate to a worth of $18.87 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 13.2%.
The escalation in the projected period can be credited to increased healthcare investments and endeavors, patient inclination towards therapies based at home, worldwide initiatives to decrease the dependence on dialysis. Predominant trends anticipated during the forecast period encompass the amalgamation of sensors and tracking devices, the incorporation of telehealth, emphasis on biocompatibility and immunogenicity, the enhancement of a regulatory framework, as well as international collaborations and research consortiums.
What Key Factors and Trends are Driving the Growth of the Artificial Kidney Market?
The continual surge in chronic kidney disease cases is set to stimulate the expansion of the artificial kidney market. Chronic kidney disease unfolds as a persistent condition whereby the kidneys gradually lose their functionality over a period of time. The predominant use of artificial kidneys is for chronic kidney disease therapy, as they extract waste products and toxins from the body, leading to fluid retention, and ensuring the right balance of electrolytes is maintained. For example, in June 2023, Kidney Research UK, a charity in the UK that undertakes research and promotes initiatives to enhance knowledge, prevention, and treatment of kidney diseases, anticipated that approximately 7.19 million people in the UK were impacted by chronic kidney disease in 2023. This accounts for over 10% of the UK population and is forecasted to rise to 7.61 million people by 2033. Consequently, the escalating count of chronic kidney disease cases fuels the growth of the artificial kidney market.
What are the Market Segments in the Artificial Kidney Market?
The artificial kidney market covered in this report is segmented –
1) By Product Type: Wearable Artificial Kidney, Implantable Artificial Kidney
2) By Dialysis: Hemodialysis, Peritoneal Dialysis, Combination
3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-User
Subsegments:
1) By Wearable Artificial Kidney: Portable Dialysis Systems, Compact Dialysis Units
2) By Implantable Artificial Kidney: Bioengineered Kidneys, Hybrid Dialysis Systems
Pre-Book The Artificial Kidney Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Artificial Kidney Market?
Advances in technology are gaining traction as a significant trend within the artificial kidney market. Major players within the market are capitalizing on innovation to maintain their market standing. For instance, NephroPlus, a dialysis network based in India, introduced Renova, a fully automated dialyzer reprocessing system equipped with inbuilt cloud storage, in July 2022. Renova is a cloud-connected device. Using the internet cloud, Biomedical Engineers can remotely troubleshoot and rectify issues. They can use the Renova app to log into the machine to monitor its status, including viewing the functioning of each of the device's valves during operations to identify any problems. Once the issue has been identified, they can then decide whether to replace a component or change a configuration setting. The dialyzer, a synthetic kidney, lowers infection risks, enhances the quality of dialysis treatment, and aids in the removal of waste products and toxins from blood, a task that compromised kidneys cannot perform.
Who Are the Key Players in the Artificial Kidney Market?
Major companies operating in the artificial kidney market include:
• Fresenius SE And Co. KGaA
• Medtronic Plc.
• Asahi Kasei Medical Co. Ltd.
• Toray Industries Inc.
• Baxter International Inc.
• DaVita Inc.
• B.Braun Melsungen AG
• UCLA Health
• Revvity
• Nipro Medical Corporation
• Nikkiso Co. Ltd.
• Kawasumi Laboratories Inc.
• Quanta Dialysis Technologies Ltd.
• Triomed AB
• Advent Access
• WearOptimo
• AWAK Technologies Pvt. Ltd.
• Aethlon Medical Inc.
• Blood Purification Technologies Inc.
• Xcorporeal Inc.
• Nanodialysis B.V
• Neokidney Development BV
• Wearable Medical Devices Inc.
• Nephria Bio Inc.
• US Kidney Research Corporation
What are the Regional Insights into the Artificial Kidney Market?
North America was the largest region in the artificial kidney market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial kidney market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
